Mineralys Therapeutics (MLYS) Other Non Operating Income (2022 - 2026)
Mineralys Therapeutics (MLYS) reported Other Non Operating Income of $5000.0 for Q1 2026, up 266.67% on a YoY basis from $1363.6 in Q1 2025, and up 400.0% sequentially from $1000.0 in Q4 2025.
Mineralys Therapeutics (MLYS) Other Non Operating Income (2022 - 2026) Analysis & Trends
Mineralys Therapeutics (MLYS) has 5 years of Other Non Operating Income data on file, last reported at $5000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income rose 266.67% year-over-year to $5000.0; the trailing twelve-month figure through Mar 2026 stood at $8000.0 (up 700.0% YoY), and the FY2024 full-year result was $5000.0, up 66.67% from the prior year.
- Other Non Operating Income grew to $5000.0 in Q1 2026, from $1000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $12000.0 in Q4 2024 to a low of -$10000.0 in Q3 2024.
- A 5-year average of $1307.7 and a median of $1000.0 in 2023 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income soared 1100.0% in 2024 and plunged 400.0% in 2025, its largest moves.
- Tracing MLYS's Other Non Operating Income over 5 years: stood at $4000.0 in 2022, then tumbled by 75.0% to $1000.0 in 2023, then soared by 1100.0% to $12000.0 in 2024, then slumped by 91.67% to $1000.0 in 2025, then soared by 400.0% to $5000.0 in 2026.
- Business Quant data shows MLYS's Other Non Operating Income at $5000.0 in Q1 2026, $1000.0 in Q4 2025, and $4000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mineralys Therapeutics | 2.24 Bn | 2.24 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Jun 30, 2025 | -2,000.00 |
| Mar 31, 2025 | -3,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Sep 30, 2024 | -10,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Sep 30, 2022 | 4,000.00 |